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Abstract 
A burst of endothelial derived oxidants including hydrogen peroxide (H 202) and superoxide ( .0  2) occurs on reperfusion of ischemic 
tissues that directly causes injury; however, it is not known if this also triggers further injury due to subsequent leukocyte adhesion and 
adhesion molecule xpression. Therefore, studies were performed in an isolated heart model developed to enable study of the role of 
isolated cellular and humoral factors in the mechanism of postischemic injury. Isolated rat hearts were subjected to 20 min of 37°C-global 
ischemia |ollowed by reperfusion with polymorphonuclear leukocytes (PMNs) and plasma in the presence or absence of superoxide 
dismutase (SOD), 200 U/ml, or catalase, 500 U/ml. Measurements of contractile function, coronary flow, high-energy phosphates, free 
radical generation, and PMN accumulation were performed. Adhesion molecule expression was measured on the surface of effluent 
PMNs by fluorescence flow cytometry and within the tissue using immunohistochemistry. SOD or catalase treatment resulted in 2- to 
3-1bid higher recoveries of contractile function, coronary flow, and high energy phosphates. EPR spin trapping measurements 
demonstrated that SOD totally quenched the free radical generation observed upon reperfusion while catalase prevented the formation of 
hydroxyl and alkyl radicals derived from superoxide. SOD or catalase treatment decreased PMN accumulation i  the reperfused heart and 
prevented the marked upregulation of CDI8 expression seen after reperfusion. These experiments demonstrate hat in addition to their 
direct antioxidative actions, SOD and catalase ach decrease PMN adhesion and CDI8 expression resulting in marked suppression of 
PMN-mediated injury in the postischemic heart. Thus, endothelial derived H202 and .O~ further amplify postischemic njury by 
triggering CD 18 expression on the surface of PMNs leading to increased PMN adhesion within the heart. 
Kevwords: Free radical: Oxidant; Inflammation; Integrin expression; Ischemia; Reperfusion injury 
1. Introduction 
While timely reperfusion of the ischemic heart can 
reduce the amount of cell death after acute coronary artery 
occlusion, there is evidence that reperfusion can cause 
further damage to jeopardized cells [1,2]. The generation 
of reactive oxygen free radicals has been shown to be an 
Abbreviations: PMNs, polymorphonuclear leukocytes; SOD, superox- 
ide dismutase; -O~, superoxide: H20 ~, hydrogen peroxide; .OH, hy- 
droxyl radical: HOCI , hypochlorite anion; LTB 4, leukotriene B4; PAF, 
platelet activating factor: Pipes, piperazine-N,N'-bis-[2-ethanesulfonic 
acid]; PAG, Pipes buffer containing human serum albumin and glucose; 
PBS+BSA, Dulbecco's phosphate buffered saline containing bovine 
serum albumin; DMPO, 5,5-dimethyl-l-pyrroline-N-oxide; EPR, electron 
paramagnetic resonance; LVDP, left ventricular developed pressure; RPP, 
rate-pressure product and, ICAM, intercellular adhesion molecule. 
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important mechanism of this myocardial reperfusion injury 
[3]. Studies demonstrating reduced infarct size and in- 
creased functional recovery in hearts treated with antioxi- 
dant enzymes have provided indirect evidence of free 
radical mediated reperfusion injury [3,4]. In addition, direct 
and spin trapping EPR measurements have demonstrated 
that there is a burst of oxygen fYee radical generation with 
the generation of superoxide, hydrogen peroxide, and hy- 
droxyl free radicals during the early minutes of reperfusion 
[5]. In the presence of polymorphonuclear leukocytes, 
PMNs, the magnitude and duration of this free radical 
generation is greatly increased [6]. 
It has been shown that superoxide and hydroxyl radicals 
are generated in reoxygenated vascular endothelial cells in 
sufficient concentrations to cause cellular injury and death 
[7]. There is evidence indicating that this endothelial radi- 
cal generation promotes both recruitment of PMNs as well 
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as activation and subsequent endothelial cell-PMN adher- 
ence [8,9]. An adhesion molecule constitutively expressed 
on the PMN membrane, the CD18 glycoprotein complex, 
has been recently identified as one of the main mediators 
of PMN adherence to vascular endothelium as it rapidly 
alters its number or functional state in response to specific 
stimuli [10,11]. Once activated, PMNs adhere to endothe- 
lial cells and then diapedese through the endothelium to 
the myocardial parenchyma. The PMNs then adhere to 
myocytes and release free radicals and other pro-inflamma- 
tory mediators. These factors amplify reperfusion injury in 
situ due to the short diffusion distance to the myocyte from 
the adherent PMN [11]. 
Previous studies [3,12-14] have shown that postis- 
chemic myocardial dysfunction and cell death can be 
attenuated by administration of the antioxidative enzymes, 
superoxide dismutase, SOD, or catalase. Since SOD and 
catalase are specific enzymes which function to dismutate 
-O? to H202 and to reduce H~O~ to H20, respectively, 
these data provide strong evidence that -O~ and H202 
play an important role in postischemic heart injury. A 
number of recent studies also have shown that similar 
beneficial effects can be seen with specific monoclonal 
antibodies to the PMN adhesion molecule CD18 [10,15]. 
While both of these therapeutic approaches have yielded 
similar beneficial effects with significant myocardial pro- 
tection, there has been little if any information regarding 
whether oxidants and free radicals generated in the postis- 
chemic heart can trigger PMN adhesion and adhesion 
molecule expression. It is, thus, unknown if there is a 
direct cause and effect relationship between postischemic 
free radical generation and the process of PMN adhesion 
and inflammation i  the postischemic heart. 
Therefore, the overall objective of this study was to 
determine the role of endogenously generated superoxide 
and hydrogen peroxide on the induction of PMN adhesion, 
PMN activation, and PMN-mediated injury in the postis- 
chemic heart. An isolated perfused rat heart model was 
used in which the effects of isolated cellular or humoral 
elements could be determined. Hearts were subjected to 
ischemia and reperfusion with PMNs and plasma, in the 
presence or absence of SOD or catalase. Measurements of
contractile function, coronary flow, free radical generation, 
PMN accumulation and CDI8 expression were performed. 
These experiments demonstrate that in addition to their 
direct antioxidative actions, SOD and catalase each de- 
crease PMN adhesion and CD18 expression, resulting in 
marked suppression of PMN-mediated injury in the postis- 
chemic heart. 
2. Materials and methods 
2. l. Isolated heart preparation 
Female Sprague-Dawley rats (300-400 g) were hep- 
arinized and anesthetized with intraperitoneal sodium 
pentobarbital (30-35 mg/kg),  and their hearts excised. 
The ascending aorta was rapidly cannulated and perfused 
at a constant pressure of 80 mmHg with a modified Krebs 
bicarbonate peffusate (in raM: 16.7 glucose, 120.0 NaCI, 
25.0 NaHCO 3, 2.5 CaC12, 0.5 EDTA, 5.9 KC1, and 1.2 
MgCI~_) at 37°C. The perfusate was prefiltered with 1.2-t~m 
pore cellulose filters and then bubbled with 95% 02/5% 
CO_,. Two side arms in the perfusion line located just 
proximal to the aortic cannula allowed infusion with a 
syringe pump of PMNs, and plasma directly into the heart 
at a 1:20 dilution with respect o the perfusate buffer. Rat 
blood was obtained by right ventricular puncture with a 
heparinized syringe and plasma obtained by centrifugation 
at 1500 × g for 20 rain. The plasma was centrifuged and 
stored at 4°C. 
Contractile function was measured using a fluid-filled 
latex balloon inserted into the left ventricle and connected 
via a hydraulic line to a Spectramed P23XL pressure 
transducer with pressures recorded on a Gould RS3400 
four-channel recorder. The balloon was inflated to produce 
an initial end-diastolic pressure of 8-12 mmHg and all 
subsequent measurements were performed at this same 
end-diastolic volume [16]. 
The experimental preparation used in this study utilizes 
the infusion of human PMNs and rat plasma into isolated 
perfused rat hearts subjected to transient periods of is- 
chemia and reperfusion. This preparation has been de- 
scribed and extensively validated in previously published 
studies [6,17]. The model was developed to evaluate the 
role of isolated cellular and humoral factors in the mecha- 
nism of postischemic injury in the heart. We have previ- 
ously observed that PMNs markedly amplify the process 
of postischemic njury, however, plasma factors including 
active complement must be present for the activation of 
PMNs with resultant contractile dysfunction [6]. 
2.2. Experimental protocol 
After a 10- to 15-min equilibration period, baseline left 
ventricular pressures, coronary flow, and heart rate were 
measured. Hearts were then subjected to a l-rain preis- 
chemic control infusion of PMNs (0.5 million PMNs/ml 
of perfusate, 10 million total) and rat plasma (5% vol with 
respect o perfusate), to verify that the human PMNs and 
rat plasma did not cause injury before ischemia. Re-equi- 
libration with perfusate alone was then performed for 5 
rain. Subsequently, the hearts were similarly infused with 
PMNs and plasma during the 30-s just prior to the onset of 
ischemia. At the onset of ischemia, the intraventricular 
balloon was deflated, and after the 20-min period of 
ischemia, at the time of reperfusion it was reinflated with 
the same volume. During the first 5 rain of reperfusion, the 
hearts were again subjected to infusion of PMNs (50 X 10 6) 
and plasma (5% vol), after which reperfusion was contin- 
ued with perfusate alone for 40 min. Serial hemodynamic 
measurements were performed every 5 rain. 
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In order to evaluate the role of superoxide and hydrogen 
peroxide on PMN-mediated contractile dysfunction i  this 
model, three experimental groups were studied: an un- 
treated group of 12 hearts, an SOD treated group of 7 
hearts treated with 200 U/ml  dissolved in plasma and a 
catalase treated group consisting of 7 hearts treated, 500 
units/ml dissolved in plasma. Plasma with or without he 
SOD or catalase was infused during the 30-s preischemic 
and 5 min reperfusion periods. The coronary effluent was 
collected during each PMN infusion to estimate PMN 
retention and CD18 expression. 
2.3. Leukocyte purification and preparation 
Human PMNs were isolated from freshly sampled ve- 
nous blood of volunteers by the Percoll density gradient 
centrifugation method [18], which yielded PMNs with a 
purity of > 95%. Each 10 ml of whole blood was mixed 
with 0.8 ml of 0.1 M EDTA (tetrasodium salt) and 25 ml 
of saline. The diluted blood was layered over 9 ml of 
Percoll at a specific density of 1.080 g/ml. After centrifu- 
gation at 400× g for 20 min at 20°C, the plasma, 
mononuclear cell, and Percoll layers were removed. Ery- 
throcytes were lysed by the addition of 18 ml of ice-cold 
water for 30 s, followed by 2 mt of 10 × Pipes (pipera- 
zine-N,N'-bis-[2-ethanesulfonic acid]) buffer. Pipes buffer 
contains 25 mM Pipes, 110 mM NaC1, 5 mM KC1, and is 
titrated to pH 7.4 with NaOH. Cells were pelleted at 4°C, 
the supernatant was decanted, and the procedure was re- 
peated. After the second hypotonic lysis, cells were washed 
twice with PAG buffer (Pipes buffer containing 0.003% 
human serum albumin and 0.1% glucose). Afterwards, 
PMNs were counted by light microscopy on a hemacy- 
tometer. 
To ensure that the PMNs possessed a potential for 
activation after isolation, cells were stimulated with 10 
ng/ml of 12-O-tetradecanoylphorbol- 13-acetate (TPA) and 
changes in CD18 expression were measured by fluores- 
cence flow cytometry as described below. We observed 
that after stimulation more than 2-fold upregulation of 
CDI8 occurred. EPR spin trapping measurements, as de- 
scribed below, demonstrated nomeasurable radical genera- 
tion in isolated unstimulated PMNs but marked radical 
generation after exposure to TPA. These measurements 
showed that the PMNs were not significantly activated by 
the process of isolation and that these cells retained the 
ability to be activated as demonstrated by functionally 
relevant markers of PMN adhesion and free radical genera- 
tion. 
2.4. Indirect immunofluorescence and f low cytometric as- 
says 
Flow cytometry was used to quantitate CD18 adhesion 
molecule xpression on PMNs collected from the coronary 
effluent. To avoid the effects of any potential alterations in 
pH and of other ions on monoclonal antibody binding of 
the effluent PMNs, these were washed and suspended in 
Dulbecco's phosphate buffered saline containing 0.2% 
bovine serum albumin (PBS + BSA) at pH 7.4. Using a 
protocol adapted from previously reported techniques, 
aliquots of 10 6 cells were labeled for 30 rain at 4°C using 
a monoclonal antibody anti-CD18 (H52) as the primary 
antibody [19]. The monoclonal antibody H52 is an IgG~ 
isotype and a concentration f 30 Ixg/ml was shown to be 
saturating in prior titration experiments. After primary 
labeling, the PMN suspension was then washed with PBS 
+ BSA, and resuspended and incubated with 5 Ixg/ml of 
goat anti-mouse IgG R-phycoerythrin-conjugated s c- 
ondary antibody for 30 min at 4°C in the dark, The cells 
were then washed again. Samples were ran through a 
Coulter EPICS fluorescence flow cytometer. Gating of the 
forward and side scatter diagrams was used to circum- 
scribe the analysis to a homogeneous cell population, 
excluding clusters and debris. The excitation and emission 
wave lengths were 488 nm and 578 nm, respectively. A 
frequency distribution histogram of the fluorescent signal 
was obtained from at least 5000 cells for each sample. 
Mode fluorescence was used as an index of labeling 
intensity and for each sample, the fluorescence of the cells 
labeled with an irrelevant, non-binding, isotype-matched 
IgG 1 primary antibody was subtracted to account for the 
non-specific background (negative control). Data were ex- 
pressed either as arbitrary units, or as percentage of the 
label-matched untreated sample (termed as control), to 
account for variability of basal values among different 
experiments. 
2.5. Electron paramagnetic resonance measurements 
Additional rat hearts were isolated and peffused as 
described above except hat no EDTA was included in the 
perfusate. The experimental protocol remained the same 
except hat the spin trap 5,5-dimethyl-l-pyrroline-N-oxide, 
DMPO, was infused through a third side arm located at the 
level of the aorta to achieve a final concentration of 40 
mM in the heart. Periodic collections of the effluent were 
made in 20-s aliquots prior to ischemia nd for the first 2, 
5, 7.5, and 10 min of reperfusion. Care was taken to keep 
the DMPO-containing solutions covered to prevent any 
light-induced egradation. 
Electron paramagnetic resonance, EPR, spectra were 
recorded in an EPR flat cell at room temperature with a 
Braker-IBM ER 300 spectrometer operating at X-band 
using a TMI10 cavity, a modulation frequency of 100 kHz, 
modulation amplitude of 0.5 G, microwave power of 20 
roW, and microwave frequency of 9.77 GHz. Each spectral 
acquisition file was the sum of ten 1-min scans. The digital 
Braker spectral data were transferred to a personal com- 
puter for analysis. Software capable of isotropic spectral 
simulation, was used for component analysis of experimen- 
tal spectra as described previously [20]. Spectral stmuta- 
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tions consisting of linear combinations of the component 
signals were performed to match the observed spectra. 
From the weighted intensities of each component in these 
simulations, the relative amount of each component signal 
can be determined [20]. 
2.6. High-energy phosphate measurements 
Following 45-min reperfusion, untreated, SOD-treated, 
and catalase-treated hearts (n = 4/group) were frozen in 
liquid nitrogen and stored at 80°C. High energy phosphates 
were acid-extracted from the hearts using the method of 
Hull-Ryde et al. [21]. The ATP concentration in the extract 
was determined using high-performance liquid chromatog- 
raphy (HPLC) on a Waters HPLC system, consisting of a 
model 484 UV detector, two model 510 reciprocating 
pumps, a system interface module, and Maxima ® soft- 
ware. 
2.7. Histology and immunohistochemistry 
After completion of the experiments, hearts were rapidly 
removed from the cannula, and the ventricles liced into 
3-5 mm thick sections, which were immediately immersed 
in a 10% formalin solution and stored at 4°C. Histological 
processing was done by conventional methods with hema- 
toxylin and eosin staining. The histological samples were 
examined for the extent of PMN infiltration in myocardial 
parenchyma and surrounding areas of capillaries and arteri- 
oles. Immunohistochemical staining was used to further 
characterize the presence of PMNs and PMN CDI8 ex- 
pression in the hearts. Tissue processing and staining was 
performed as described previously using a 1:800 dilution 
of primary antibody against common leukocyte antigen, 
CLA (MCA-43), and a 1:400 dilution of the primary 
anti-CD18 antibody (MCA-775) [17]. For all measure- 
ments standard negative controls using either no primary 
or no primary and secondary antibodies were performed 
and failed to show any staining. 
2.8. Chemicals and reagents 
The chemicals and reagents used in this study were 
purchased from the sources indicated: ingredients of the 
modified Krebs perfusate, Pipes, bovine erythrocyte SOD 
4000 U/mg, BSA fraction V, paraformaldehyde, and bio- 
tinylated goat anti-mouse IgG (Sigma Chemical Co., St. 
Louis, MO); human serum albumin (Calbiochem Corp., La 
Jolla, CA), Percoll (Pharmacia LKB, Biotechnology AB; 
Uppsala, Sweden); catalase 65000 U/mg (Boehringer 
Mannheim Corp., Mannheim, Germany); Dulbecco's PBS 
(GIBCO Laboratories; Grand Island, NY); goat anti-mouse 
IgG R-phycoerythrin-conjugated antibody (TAGO, 
Burlingame, CA); irrelevant non-binding antibody for IgG 1 
(AMAC, Westbrook, ME); mouse anti-CLA, MCA-43, 
and mouse anti-CD18, MCA 775 (Harlan Bioscience, Indi- 
anapolis, IN), and DMPO (Aldrich Chemical Co., Milwau- 
kee, WI). Double-distilled, eionized water was used to 
prepare the perfusate and all other solutions. 
2.9. Statistical analysis 
Data are presented as mean ___ standard error, with eval- 
uation of statistical significance by analysis of variance 
designed for repeated measures. A P value of 0.05 was 
considered to indicate statistical significance. 
3. Results 
3.1. Hemodynamic and bioenergetic data 
3.1.1. Left ventricular developed pressure 
Preischemic baseline values of developed pressure did 
not differ significantly among the three groups of hearts 
studied (111.7 + 7.8 mmHg). After 15 min of reperfusion, 
untreated hearts recovered only 25.4 + 8.2% of baseline 
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Fig. 1. Graphs of the recovery ofhemodynamic function upon reperfusion 
after 20 min global ischemia. A, left ventricular developed pressure; B,
left ventricular end-diastolic pressure; and C, coronary flow. For A and 
C, values are expressed as percent ofpreischemic values. Data re plotted 
as mean ± SEM. Recovery of all parameters was markedly improved, 
both by SOD or catalase treatments, compared to untreated hearts. 
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developed pressure, increasing radually to 31.3-t- 10.0% 
of baseline at 45 min of reperfusion (Fig. 1A). SOD-treated 
hearts recovered 80.7 5: 3.0% of baseline developed pres- 
sure at 15 min and 96.1 _ 3.0% of baseline at 45 rain 
(P<0.01) .  Likewise, catalase-treated hearts recovered 
83.3 5: 9.7% of baseline developed pressure after 15 min 
and 88.3 + 7.5% after 45 min of reperfusion (P  < 0.01 vs. 
untreated hearts and P = not significant, NS, vs. SOD- 
treated hearts). Thus, both SOD-treated and catalase-treated 
hearts exhibited a much greater ecovery of LVDP than 
untreated controls. 
3.1.2. Rate-pressure product 
The product of heart rate and left ventricular developed 
pressure, the rate-pressure product (RPP), was measured as 
a hemodynamic ndex of cardiac work. Untreated, SOD- 
treated, and catalase-treated hearts exhibited similar mean 
baseline RPPs (22.8 ___ 3.8 • 103 beats- mmHg/min). After 
15 min of reperfusion the observed recovery of RPP was 
24.8 ___ 9.7%, 77.7 + 4.8%, and 79.3 -t- 11.9% for un- 
treated, SOD-treated, and catalase-treated hearts, respec- 
tively. After 45 min of reperfusion, the recoveries were 
29.9 _ 8.9% for untreated hearts, 88.9 + 5.0% for SOD- 
treated hearts (P  < 0.01 vs. untreated hearts), and 86.9 _ 
6.8% for catalase-treated hearts (P  < 0.01 vs. untreated 
hearts and P = NS vs. SOD-treated hearts). Thus, again 
throughout the time course of reflow considerably higher 
recovery was observed in SOD- or catalase-treated hearts 
than in the matched controls. 
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Fig. 3. Graph of the levels of PMN CD18 expression. Measured by 
fluorescence flow cytometry on basal PMNs and on PMNs collected from 
the 1-min preischemic (PI), 30-s preischemic, and 5-min reperfusion (RP) 
infusions. Values expressed in mode fluorescence intensity, are plotted as 
mean + SEM, and are compared by two-way analysis of variance. For 
untreated and treated hearts, CD18 surface expression on the PMNs 
collected after the 1-min and 30-s preischemic nfusions were similar to 
basal expressions. A marked upregulation of PMN CD18 expression 
occurred in the untreated hearts compared to l-min preischemic values, 
* *P  < 0.02. This effect was decreased by either SOD or catalase 
treatment. * P < 0.05; * * P < 0.02. 
15 min of reperfusion, end-diastolic pressures then de- 
clined slowly. The untreated and treated hearts exhibited 
clearly different values: 80.6 + 8.0 (untreated hearts), 12.6 
_ 3.1 (SOD-treated hearts), and 20.0 _ 4.9 (catalase- 
treated hearts) mmHg. Final end-diastolic pressures were 
77.7 + 7.8 mmHg for untreated hearts, 9.7 + 3.3 mmHg 
3.1.3. Left ventricular end-diastolic pressure 
Untreated, SOD-treated, and catalase-treated hearts had 
similar end-diastolic pressures during the equilibration pe- 
riod, with values of 13.3 ___ 1.5, 11.7 -I- 1.8, and 12.9 -I- 0.6 
mmHg, respectively (Fig. 1B). However, at after reperfu- 
sion, higher end-diastolic pressures were observed in all 
three groups indicating impaired iastolic relaxation. After 
I I Untreated t - - - i SOD B Catalase 
t ¢.. 
ne 
Z 
[ ]  Untreated [ ]  SOD [ ]  Catalase 
1-Min PI 30-Sec PI 
II 
5-Min RP 
Fig. 2. Graph of PMN retention in the heart. Values shown are for the 
l-rnin preischemic (1-min PI), the 30-s infusion just prior to ischemia 
(30-s PI), and the 5-min postischemic infusion (5-min RP). Data ex- 
pressed as percentage of PMNs infused, are plotted as mean -I- SEM, and 
are statistically analyzed by two-way analysis of variance. SOD ( * P < 
0.02) and catalase (* * P < 0~01) significantly attenuated PMN retention 
during the first 5 min of reperfusion compared to untreated hearts. 
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Fig. 4. Flow cytometry histograms showing cell number vs. fluorescence 
intensity from experiments evaluating the effect of SOD and catalase on 
PMN CD18 expression. Marked CD18 upregulation (a shift to the right) 
was observed after 20 min of global ischemia, which was attenuated by 
SOD or catalase. 
196 C.V. Serrano, Jr. et al./Biochimica et Biophysics Acta 1316 (19961 191-202 
Fig. 5 
Fig. 6 
C. V. Serrano, Jr. et al. / Biochimica et Biophysica Acta 1316 (1996) 191-202 197 
for SOD-treated hearts (P  < 0.01 vs. untreated hearts), and 
13.4 + 3.8 mmHg for catalase-treated hearts (P  < 0.01 vs. 
untreated hearts and P = NS vs. SOD-treated hearts). Thus, 
in the SOD- or catalase-treated hearts diastolic relaxation 
returned to normal with end-diastolic pressure returning to 
baseline values, while in the untreated hearts left ventricu- 
lar end-diastolic pressure remained considerably elevated. 
3.1.4. Coronary f low 
Mean coronary flows measured before the onset of 
global ischemia for the untreated, SOD-treated, and cata- 
lase-treated hearts were 19.9 + 2.3, 20,0 + 1.5, and 18.9 + 
0.5 ml /min ,  respectively. After 15 min of reperfusion, the 
coronary flows recovered 28.7 ___ 10.7% for the untreated 
hearts, 92.7 + 7.2% for the SOD-treated hearts, and 80.6 
+ 9.3% for the catalase-treated hearts (Fig. IC). The final 
recoveries were 32.3 + 8.7% for untreated hearts, 82.9 + 
4.5% for SOD-treated hearts (P<0.01  vs. untreated 
hearts), and 74.6 ± 5.4% for catalase-treated hearts (P  < 
0.03 vs. untreated hearts and P = NS vs. SOD-treated 
hearts). Thus, coronary flow also exhibited much greater 
recovery in the SOD- or catalase-treated hearts. 
3.1.5. ATP leL, els 
The ATP concentrations in whole hearts following the 
45-min reperfusion for the untreated, SOD-, and catalase- 
treated hearts were 0.24 + 0.04, 1.10 + 0.06 (P  < 0.01 vs. 
untreated hearts), and 0.69 + 0.15 (P  < 0.03 vs. untreated 
hearts and P < 0.05 vs. SOD-treated hearts) Ixmol /g  wet 
wt., respectively. ATP levels in non-ischemic, non-treated 
hearts were 3.7 + 1.2 ixmol /g  wet wt. Thus, SOD- or 
catalase-treated hearts exhibited a markedly improved bio- 
energetic state compared to untreated controls, with 3- to 
4-fold higher concentrations of ATP present in the treated 
hearts. 
3.2. PMN retention 
To determine whether PMN retention was effected by 
treating the hearts with SOD and catalase during ischemia 
and reperfusion, and thus to infer, whether this PMN 
retention might be influenced by the generation of .02  or 
H20 ~ within the heart, measurements of PMN retention 
were performed. PMN retention was calculated as the 
differential count between the amount of PMNs infused in 
the 1-min preischemic, 30-s preischemic, and 5-min reper- 
fusion periods and the total number of PMNs collected in 
the respective coronary effluents. The quantity of PMNs 
retained under preischemic conditions did not differ signif- 
icantly between the untreated and treated hearts (Fig. 2). 
However, SOD and catalase did decrease PMN retention 
during the first 5 rain of reperfusion when compared to 
untreated hearts: 41.4 _+ 9.9% for untreated hearts vs. 25.4 
+ 6.7% for SOD-treated hearts (P  < 0.02) and 7.4 + 2.1% 
for catalase-treated hearts (P  < 0.01). Thus, SOD signifi- 
cantly decreased the retention of PMNs within the my- 
ocardium with almost a two-fold reduction while catalase 
markedly decreased PMN retention by almost six-fold. 
3.3. Quantitation of  CD18 cell surface expression on 
leuko£vtes 
Initial studies using flow cytometric techniques were 
performed to establish the basal PMN surface expression 
of CDI8 in each group. Aliquots of freshly prepared 
PMNs were evaluated for CD18 expression before infu- 
sion. The PMNs used in the untreated, SOD-treated, and 
catalase-treated hearts were observed to have similar basal 
CDI 8 expression with mode fluorescence intensity of 65.6 
_+ 10.8, 73.8 ± 12.4, and 62.3 + 11.3, respectively (Fig. 
3). CD18 expression of PMNs collected in the coronary 
effluent of the l-rain preischemic infusion also did not 
show significant differences among untreated, SOD-treated, 
and catalase-treated hearts with mode fluorescence inten- 
sity values of: 70.1 ± 3.4, 83 .5_  14.8, and 66.6 ± 15.6, 
respectively. Similar findings were observed for the 30-s 
preischemic infusion: 71.3 + 13.8, 85.6 _-6 14.9, and 65.8 
_+ 9.8 for untreated, SOD-treated, and catalase-treated 
hearts, respectively. Thus, it was observed that PMN CD18 
expression was not altered upon traversing the circulation 
of the preischemic heart. Measurements of the PMNs 
infused and collected uring the 5-min postischemic infu- 
sion, however, demonstrated in untreated hearts that there 
was a marked increase in CD18 expression, with a value of 
193.4_+ 3.9 (P  < 0.02 vs. respective 1-min preischemic 
CDI 8 expression). With the administration of SOD, CD 18 
expression was limited to 100.3 + 6.2 (P  = NS vs. respec- 
tive 1-min preischemic CD18 expression and P < 0.05 vs. 
Fig. 5. Photomicrographs s owing myocardial histology in (a) untreated, (b) SOD treated or (c) catalase treated hearts. In untreated tissue, note the 
presence of a line of PMNs in a microvessel (dashed lines), the infiltration of PMNs within the interstitium (dotted line), and the disrupted myofibrillar 
structure (solid lines). In the SOD- and catalase-treated h arts less accumulation f PMNs in microcirculatory vessels was associated with preservation f 
myocardial structure. Original magnification 100 ×. 
Fig. 6. Immunoperoxidase staining of heart issue for common leukocyte antigen, CLA. top row; and CDI8 bottom row. Tissue from untreated control 
hearts (A and C, 400 × ) and SOD-treated hearts (B, and D 250 × ) is shown. A, untreated control hearts were found to contain large clusters of CLA 
positive cells both within the microvascular bed and within the interstitial space. B, SOD treated hearts had much fewer CLA positive cells seen scattered 
throughout the microvasculature. C, CD 18 positive cells are seen diffusely within the microvascular bed in untreated hearts whereas in SOD treated hearts, 
D, only rare focal clusters of CDI8 positive staining were seen. Note the increased interstitial space between myocytes which corresponds to interstitial 
edema in the untreated heart issue. Catalase treated hearts exhibited similar patterns of staining to that of the SOD-treated hearts hown. 
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untreated hearts) and with catalase, to 73.9 + 5.5 (P  = NS 
vs. respective 1-min preischemic CD18 expression, P < 
0.02 vs. untreated hearts, and P = NS vs. SOD-treated 
hearts) (Fig. 3). Fig. 4 shows typical flow cytometry 
histograms observed from these experiments measuring 
CDl 8 expression of basal PMNs and PMNs collected from 
the preischemic and postischemic infusions of untreated 
and treated hearts. 
3.4. Histology and immunohistology 
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Histological experiments were performed to measure 
the presence and localization of PMNs within hearts from 
each of the three groups. In untreated hearts numerous 
PMNs were observed within myocardial arterioles, capil- 
laries, and interstitial spaces that were associated with 
disrupted myofibril lar structure; while in the SOD- or 
catalase-treated hearts few PMNs were seen and myofibril- 
lar structure appeared preserved (Fig. 5). Thus, it was 
observed that either SOD or catalase treatment appeared to 
prevent he adhesion of PMNs to the endothelium of the 
microcirculatory vessels of the heart and this was associ- 
ated with less myocyte injury. 
To further confirm the presence of leukocytes within 
the tissue and to measure the expression of CD18 on the 
leukocytes immunohistochemistry studies were performed 
using the immunoperoxidase t chnique. When untreated 
heart tissue was stained for CLA numerous clusters of 
PMNs were observed within arterioles, capillaries, and 
interstitial spaces (Fig. 6A), These PMNs exhibited strong 
staining for CD 18 (Fig. 6C). In the SOD or catalase treated 
hearts only few scattered PMNs were seen which stained 
positive for CDI8, however, much less positive staining 
for CD18 was seen throughout hese slides (Fig. 6B,D). 
Thus, it was observed that either SOD or catalase treat- 
ment prevented the upregulation of CD18 on the PMN 
surface which in turn decreased the adhesion of PMNs to 
the endothelium of the microcirculatory vessels resulting 
in less myocyte injury. 
3.5. Measurement of  oxygen-free radical generation 
EPR measurements were performed in untreated, SOD- 
treated or catalase-treated hearts using the spin trap DMPO, 
which reacts with primary unstable free radicals such as 
• O~, .OH, or .R to give rise to more stable spin trap 
radical adducts. In untreated hearts prominent free radical 
generation was observed with the appearance of a complex 
EPR spectrum which consisted primarily of the DMPO-OH 
Fig. 7. Electron paramagnetic (EPR) spectra of coronary effluent from 
untreated control (top panel), catalase-treated (middle panel), and SOD- 
treated hearts (bottom panel) measured in the presence of40 mM DMPO. 
For each panel the top tracing, A, shows the preischemic spectrum, while 
the lower tracing, B, shows the spectrum observed over the first 2 rain of 
reperfusion. No signal was observed in any of the preischemic measure- 
ments, however, prominent free radical generation was observed in 
untreated hearts with the appearance of DMPO-OH and DMPO-R radical 
adducts. In SOD-treated hearts this radical generation was quenched, 
while in the catalase-treated h arts the DMPO-OH signal exhibited only a 
small 30% decrease and the DMPO-R signal disappeared. 
C V. Serrano. Jr. et al. / Biochimica et Biophysica Acta 1316 (1996) 191-202 199 
D 
I I I I I I I 
3433 3483 3533 
Magnetic Field (Gauss) 
Fig. 8. Computer simulation of the EPR spectrum from an untreated heart 
as described in Fig. 6. A, experimental EPR spectrum. B, simulated 
spectrum of the DMPO-OH adduct which exhibits a 1:2:2:1 quartet signal 
(a N = a H = 14.96 G linewidth = 1.38 G). C, simulated spectrum of the 
DMPO-R adduct (a s, = 15.6 G a H = 22.7 G and linewidth = 1.4 G). D, 
simulated spectrum of DMPO-H (a N = 16.9 G a H = 22.1 G and linewidth 
1.5 G). E, best fit simulation of the experimental spectrum, A, obtained 
from the sum of B, C, and D. Thus, it is shown that the complex 
experimental spectrum arises from a linear combination of the DMPO-OH, 
DMPO-R and DMPO-H radical adducts with relative intensity weighting 
of 0.43.0.37, and 0.2, respectively. 
and DMPO-R free radical adduct signals (Fig. 7, top 
panel). The simulation of the observed EPR spectrum 
shown in Fig. 8 demonstrates that this spectrum can be 
explained by a linear combination of the 1:2:2:1 quartet 
signal of DMPO-OH and the 1 : 1 : 1 : 1 : 1 : 1 signal of DMPO-R 
with an additional small component signal of DMPO-H. 
These radical signals appeared as early as the first 20 s of 
reperfusion and persisted uring the first 10 min of reper- 
fusion. As noted previously, in the untreated hearts reper- 
fused in the presence of PMNs and plasma radical genera- 
tion persists much longer than in the absence of PMNs 
where a brief burst is seen only during the first 5 min of 
reflow [6]. In SOD-treated hearts this radical generation 
was quenched with more than a 90% decrease in the 
magnitude of the observed signals throughout the mea- 
sured time course of reperfusion, while in the catalase- 
treated hearts the DMPO-OH signal exhibited only a small 
30% decrease but the DMPO-R signal totally disappeared 
(Fig, 7, middle and bottom panels). These results suggest 
that the observed DMPO-OH signal arises at least 70% 
from the direct trapping of -0 2 and thus can be directly 
quenched by SOD. The remaining 30% of the DMPO-OH 
signal may be derived from trapping of -OH and the 
DMPO-R signal corresponds to trapping of alkyl radicals. 
These radicals are probably generated by .OH mediated 
hydrogen abstraction of lipids or proteins. There is previ- 
ous evidence that -OH is generated within the postis- 
chemic heart via iron mediated Fenton chemistry [16]. In 
the presence of catalase which scavenges the hydrogen 
peroxide required for the formation of the hydroxyl radi- 
cal, both hydroxyl radical generation and alkyl radical 
generation would be blocked. Thus, these experiments 
demonstrate that while SOD scavenged superoxide and 
superoxide derived radical generation, catalase only pre- 
vented the formation of radicals generated distal to hydro- 
gen peroxide. 
4. Discussion 
Reperfusion of ischemic myocardium has been shown 
to initiate a deleterious cascade of events leading to further 
myocardial injury [1,2,22]. This phenomenon is known as 
myocardial reperfusion injury and there is evidence that 
both endothelial derived oxidants and polymorphonuclear 
leukocytes are important mediators of this injury. Studies 
have shown that oxygen free radicals are generated by 
postischemic endothelium and may enhance PMN accumu- 
lation into the ischemic region [7-9,23-25]. 
An essential initiating step in the process of PMN-medi- 
ated injury within the heart involves the adhesion of 
circulating PMNs to the coronary endothelium [15]. This is 
followed by PMN activation, diapedesis, and extravascular 
migration into surrounding myocytes. PMNs, once acti- 
vated, can degranulate secreting numerous potent prote- 
olytic and lipolytic enzymes as well as toxic and vasoac- 
tive substances [26]. Moreover, PMN activation causes a 
respiratory burst, resulting in the production of large addi- 
tional quantities of the superoxide free radical by the 
univalent reduction of O~ by membrane-bound NADPH 
oxidase [27,28]. These superoxide radicals can then dismu- 
tate to form H202.  Hydrogen peroxide, in turn, can be 
transformed to the powerful oxidant, hypochlorite anion 
(HOCI-), by the PMN enzyme myeloperoxidase in the 
presence of chloride ions [28]. Hydrogen peroxide may 
also interact with redox cyclable iron within the my- 
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ocardium, resulting in the formation of the highly reactive 
hydroxyl radical [28,29]. 
The reactive oxygen species generated either by the 
endothelial cells or the PMNs can exert cytotoxicity during 
myocardial reperfusion by disrupting cellular and mito- 
chondrial membranes [30]. The release of products of lipid 
peroxidation such as arachidonic acid into the extracellular 
space may result in the subsequent formation of prosta- 
glandins and endoperoxides, and further exacerbate the 
injury process [30]. In addition to lipid peroxidation spe- 
cific cellular enzymes and ion channels are oxidized result- 
ing in alterations in vascular smooth muscle tone as well 
as a loss of cellular membrane integrity with enhanced 
membrane fluidity and permeability [31]. A decrease in 
energy production and diminished handling of intracellular 
calcium occurs, resulting in further contractile impairment 
[29]. 
For PMN-endothelial cell adhesion to occur regulated 
expression of molecules on both the leukocyte and en- 
dothelial cell must occur. The leukocyte adherence glyco- 
proteins are a family of heterodimeric structures consisting 
of distinct a chains and a common 132 chain (CD18), and 
are, in turn, members of the integrin family of adhesion 
molecules. Following leukocyte activation conformational 
changes in the 132 integrins occur along with rapid move- 
ment of additional pre-formed molecules to the cell sur- 
face. The importance of the adhesion molecule CD18 in 
PMN adherence to endothelial cells during reperfusion 
injury has been demonstrated by studies which observed 
that treatment with a monoclonal antibody against CD 18 at 
the onset of reperfusion inhibits PMN accumulation and 
prevents PMN-mediated injury [ 10,15]. 
While it is clear that activated PMNs give rise to a 
marked oxidant burst, it is not known if the formation of 
oxidants and oxygen free radicals by the endothelium of 
the postischemic heart can trigger PMN adhesion and 
activation. We have recently reported that exogenous u- 
peroxide or hydrogen peroxide can trigger PMN adhesion 
molecule expression as well as the functional adhesion of 
PMNs to endothelial monolayers [32]. We have also previ- 
ously demonstrated in an isolated rat heart preparation, 
similar to the one used in this study, that a burst of oxygen 
radical generation occurs during the early minutes of reper- 
fusion [33]. This radical generation is largely derived from 
the endothelial enzyme xanthine oxidase [33,34] and is 
triggered by the formation of the xanthine oxidase sub- 
strates hypoxanthine and xanthine, which are formed from 
the degradation of ATP during ischemia [35]. In this study 
the role of this endogenously generated superoxide and 
hydrogen peroxide on PMN activation was determined. In 
addition, we studied the efficacy of enzymes which scav- 
enge this oxidant production in preventing PMN-mediated 
injury. 
In the present study, we observe that PMNs can induce 
marked injury in the postischemic heart with impairment 
of contractile function and decreased coronary flow. In the 
absence of SOD or catalase, hearts exhibited marked con- 
tractile dysfunction with only 30% recovery of preis- 
chemic function, while in hearts treated with SOD or 
catalase the recovery of contractile function was increased 
by more than three fold. In the untreated hearts, the 
coronary flow was decreased with a final recovery of only 
32% of preischemic values, while in the SOD- or catalase- 
treated hearts, coronary flow recovered to 83% or 75%, 
respectively. It was also observed that SOD or catalase 
prevented the increase in left ventricular end-diastolic pres- 
sure indicating that these enzymes resulted in improved 
diastolic relaxation. This is probably due to diminished 
oxidant-mediated damage to cellular membranes or en- 
zymes, with the prevention of myocyte calcium overload 
which occurs within the reperfused myocardium [14]. Thus, 
SOD and catalase greatly decreased postischemic njury as 
demonstrated by the preservation of contractile function 
and flow. 
In the reperfused hearts SOD and catalase also resulted 
in an improved bioenergetic state with almost two fold 
higher recovery of ATP. The higher levels of ATP in these 
hearts probably reflects a lower severity or incidence of 
myocyte damage and thus a greater potential for recovery 
of contractile and metabolic function. 
After ischemia nd reperfusion PMN accumulation was 
increased by two fold compared to that observed prior to 
ischemia. While SOD or catalase did not change the 
accumulation of PMNs within the heart before ischemia, 
these enzymes totally blocked the increase in PMN accu- 
mulation during reperfusion. In accordance with the in- 
crease in PMN adhesion observed after reperfusion a 
two-fold increase in CD18 expression was seen on the 
surface of PMNs from these untreated hearts. SOD or 
catalase prevented this CD18 upregulation. Thus, both 
enzymes blocked PMN accumulation i  the postischemic 
heart by preventing the increase in CDI 8 adhesion molecule 
expression. 
Histologic sections from hearts in each of the groups 
confirmed that SOD or catalase treatment decreased the 
accumulation of PMNs within the postischemic my- 
ocardium. Immunohistology studies further demonstrated 
that there were numerous PMNs adherent to the endothe- 
lium and in the interstitium of untreated hearts. These 
PMNs exhibited strong staining for CD18. In the SOD or 
catalase treated groups much fewer PMNs were seen with 
less CDI8 staining in sections from these hearts. 
EPR measurements of free radical generation were per- 
formed in each of the three groups of hearts using the spin 
trap DMPO. As reported previously in isolated buffer 
perfused hearts a burst of radical generation is observed 
during the first 5 min of reperfusion, while in the presence 
of PMNs and plasma this radical generation is prolonged 
[6]. The observed spin trap adducts consist primarily of 
DMPO-OH and DMPO-R adducts derived from superox- 
ide and .OH formed via the superoxide driven Fenton 
reaction. In untreated hearts, we observed that free radical 
C. V. Serrano, Jr. et al. / Biochimica 
generation occurred with DMPO-OH and DMPO-R adducts 
seen during the first 10 rain of reperfusion. SOD treatment 
totally quenched this radical generation, while catalase 
only prevented the generation of hydroxyl and alkyl radi- 
cals generated distal to superoxide. Thus, the administered 
enzyme concentration of SOD was sufficient to totally 
quench the radical generation measured in the coronary 
effluent, while that of catalase was sufficient to quench the 
production of hydroxyl derived alkyl radicals. These exper- 
iments served to confirm that each enzyme exerted its 
expected radical scavenging effect within the vasculature 
of the heart. 
The results from this study indicate that both superoxide 
radicals and hydrogen peroxide are important mediators of 
the leukocyte-endothelial cell interactions observed after 
reperfusion of the ischemic heart. Since both SOD and 
catalase blocked leukocyte adhesion and leukocyte medi- 
ated injury, it is likely that the hydroxyl radical or other 
secondary, oxidative products derived from the hydroxyl 
radical are responsible for the observed effects. In addition 
to triggering the upregulation of CDI 8 there are several 
other mechanisms by which .0  2 and .O2--derived radi- 
cals might trigger reperfusion-induced leukocyte adher- 
ence. It has been demonstrated that .0  2 reacts with the 
endothelial cell to produce and release humoral mediators, 
including leukotriene B 4 and platelet activating factor, 
which in turn, then activate and promote the adherence of 
leukocytes [36]. Superoxide may also induce the formation 
and expression of endothelial adhesion molecules uch as 
P-selectin or ICAM-I [9]. Another possible mechanism by 
which -0 2 might further promote PMN adhesion is by 
inactivation of nitric oxide, an endothelial derived va- 
sodilator which interferes with PMN adherence to mi- 
crovascular endothelium [37]. 
Thus, in addition to their direct antioxidant effects, 
SOD and catalase can prevent PMN adhesion molecule 
expression, PMN accumulation, and PMN-mediated reper- 
fusion injury. These data suggest hat endothelial derived 
oxidants, including superoxide and hydrogen peroxide, are 
involved in triggering PMN adhesion and PMN-mediated 
injury in the postischemic heart. 
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